# OnCo record expres2ion-biotechnologies (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/expres2ion-biotechnologies/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "expres2ion-biotechnologies" ;
  schema:name "ExpreS2ion Biotechnologies"@en ;
  schema:alternateName "ExpreS2ion"@en ;
  schema:description "ExpreS2ion Biotechnologies makes ES2B-C001, a vaccine that trains the immune system to recognise HER2, a protein found on some breast and other cancers. It is in a first trial in people with HER2-expressing breast cancer that has spread."@en ;
  schema:url <https://onco.cc/companies/expres2ion-biotechnologies/>, <https://expres2ionbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://expres2ionbio.com/>, <https://clinicaltrials.gov/study/NCT06746688> ;
  schema:addressCountry "DK" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:targets <https://onco.cc/targets/her2/> .